Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug
ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “Small Cap Growth Strategy”.
Posts Tagged ‘NASDAQ:AXSM’
10 Best Under-the-Radar Stocks to Invest In
In this article, we will discuss: 10 Best Under-the-Radar Stocks to Invest In.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2026 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2026 Earnings Call Transcript May 4, 2026Axsome Therapeutics, Inc. misses on earnings expectations.
Axsome Therapeutics, Inc. (AXSM): A Bull Case Theory
We came across a bullish thesis on Axsome Therapeutics, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on AXSM.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2025 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2025 Earnings Call Transcript February 23, 2026Axsome Therapeutics, Inc. misses on earnings expectations.
Axsome Therapeutics (AXSM) Reports 66% Revenue Growth in FY2025, Beats Analyst Estimates
Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the mid-cap stocks to buy according to top investors. On January 20, H.C.
Top Investors’ Stock Portfolio: 10 Mid-cap Stocks To Buy
In this article, we will take a look at 10 mid-cap stocks to buy according to top investors. The Fed's change from higher interest rates to rate cuts has caused what Amy Y.
Piper Sandler Bullish on Axsome Therapeutics (AXSM) Ahead of Likely Auvelity Label Expansion by April 30
Axsome Therapeutics Inc. (NASDAQ:AXSM) is one of the best mid-cap growth stocks to buy right now.
14 Best Mid-Cap Growth Stocks to Buy Right Now
On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC and suggested she sees significant upside in 2026 for undiscovered...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript November 3, 2025Axsome Therapeutics, Inc. misses on earnings expectations.
Piper Sandler Maintains Overweight on Axsome (AXSM), Sees Growth in AD-Agitation
Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the best biotech stocks to buy. Following a recent discussion with the senior management at Axsome Therapeutics Inc.
14 Best Biotech Stocks to Buy Right Now
In this article, we will take a look at the 14 Best Biotech Stocks to Buy Right Now. The biotech industry is almost always buzzing.
H.C. Wainwright Reaffirms Buy on Axsome (AXSM) Following Generic Challenge to Portfolio
Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the best mid-cap stocks with huge upside potential. H.C.
12 Best Mid-Cap Stocks with Huge Upside Potential
In this article, we will take a look at the 12 Best Mid-Cap Stocks with Huge Upside Potential.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript August 4, 2025Axsome Therapeutics, Inc. beats earnings expectations.
Morgan Stanley Assumes Coverage of Axsome Therapeutics (AXSM) with an Overweight Rating
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
Piper Sandler Reaffirms Price Target on Axsome (AXSM) Despite AXS-14 FDA Hurdle
Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.
30 Stocks Expected To Beat the Market By 20 Percentage Points This Year
The US stock market has gone through a turbulent journey this year. Following a correction in March and a lull in April, the S&P 500 recovered its losses in May and June.
Axsome’s AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is one of the 13 Biotech Stocks with Huge Upside Potential.
13 Biotech Stocks with Huge Upside Potential
In this article, we will discuss: 13 Biotech Stocks with Huge Upside Potential.
Morgan Stanley Remains Bullish on Axsome (AXSM), Reiterates $190 PT
In a report dated May 30, Morgan Stanley analyst Vikram Purohit reaffirmed his Buy rating on Axsome Therapeutics Inc. (NASDAQ:AXSM), with an unchanged price target of $190.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2025 Earnings Call Transcript
Axsome Therapeutics, Inc.
10 Best Performing Growth Stocks in 2025
In this article, we will look at the 10 Best Performing Growth Stocks in 2025.
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
10 Best Performing Pharma Stocks So Far in 2025
In this article, we will look at the 10 Best Performing Pharma Stocks So Far in 2025.
10 Best Performing Healthcare Stocks So Far in 2025
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2024 Earnings Call Transcript February 18, 2025Axsome Therapeutics, Inc. misses on earnings expectations.
Why Axsome Therapeutics (AXSM) Is Advancing Today
Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from $105.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2024 Earnings Call Transcript
Axsome Therapeutics, Inc.
Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double
We recently published a list of Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript August 5, 2024Axsome Therapeutics, Inc. misses on earnings expectations.
Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell
In this article, we will take a detailed look at Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript February 20, 2024 Axsome Therapeutics, Inc. misses on earnings expectations.
11 Best Upside Stocks To Buy Right Now
In this piece, we will take a look at the 11 best upside stocks to buy right now.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript November 6, 2023 Axsome Therapeutics, Inc. misses on earnings expectations.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2023 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2023 Earnings Call Transcript August 7, 2023 Axsome Therapeutics, Inc. misses on earnings expectations.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2023 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2023 Earnings Call Transcript May 8, 2023 Axsome Therapeutics, Inc. beats earnings expectations.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2022 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2022 Earnings Call Transcript February 27, 2023 Operator: Good morning, and welcome to the Axsome Therapeutics Conference Call.
Wall Street Analysts are Recommending These 10 Stocks in September
In this article, we will take a look at the 10 stocks recommended by analysts in September.
Top 10 Gainers on Friday
In this article, we will take a look at the top 10 gainers on Friday. Sportswear retailer Foot Locker, Inc. (NYSE:FL), entertainment conglomerate Warner Bros. Discovery, Inc.
15 Small Company Stocks You Should Own Now for the Next Decade
In this article, we discuss 15 small company stocks you should own now for the next decade. Small company stocks were heavily impacted by the recent market downturn.
Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks. Steve A.
Hedge Funds Have Never Been This Bullish On Axsome Therapeutics, Inc. (AXSM)
Is Axsome Therapeutics, Inc.
Hedge Fund Resource Center
